Prospective evaluation of low-dose warfarin for prevention of thalidomide associated venous thromboembolism-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prospective evaluation of low-dose warfarin for prevention of thalidomide associated venous thromboembolism

Published:2006-01 Issue:11 Volume:47 Page:2339-2343
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Miller Kena C.,Padmanabhan Swaminathan,Dimicelli Laurie,Depaolo Dawn,Landrigan Beverly,Yu Jihnhee,Doran Virginia,Marshal Patricia,Chanan-Khan Asher

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190600799631

Reference30 articles.

1. Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure

2. Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

3. Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL)

4. Thalidomide in relapsed/refractory multiple myeloma: pivotal trials conducted outside the United States

5. Thalidomide Alone or With Dexamethasone for Previously Untreated Multiple Myeloma

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies;JAMA Oncology;2017-07-01

2. ‘Sailing in troubled waters’;Blood Coagulation & Fibrinolysis;2016-09

3. Management of Treatment Complications and Supportive Care;Multiple Myeloma;2013-09-04

4. Thromboprophylaxis prescribing and thrombotic event rates in multiple myeloma patients treated with lenalidomide or thalidomide at a specialist cancer hospital;Asia-Pacific Journal of Clinical Oncology;2012-09-24

5. Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma;Cancer;2011-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3